BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24461457)

  • 41. A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds.
    Mustafa DA; Sieuwerts AM; Smid M; de Weerd V; van der Weiden M; Meijer-van Gelder ME; Martens JW; Foekens JA; Kros JM
    PLoS One; 2015; 10(12):e0144097. PubMed ID: 26716838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery.
    Pennock ND; Jindal S; Horton W; Sun D; Narasimhan J; Carbone L; Fei SS; Searles R; Harrington CA; Burchard J; Weinmann S; Schedin P; Xia Z
    BMC Med Genomics; 2019 Dec; 12(1):195. PubMed ID: 31856832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of recurrence risk score using 95‑gene classifier and its application to formalin‑fixed paraffin‑embedded tissues in ER‑positive, HER2‑negative and node‑negative breast cancer.
    Naoi Y; Saito Y; Kishi K; Shimoda M; Kagara N; Miyake T; Tanei T; Shimazu K; Kim SJ; Noguchi S
    Oncol Rep; 2019 Dec; 42(6):2680-2685. PubMed ID: 31638234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue.
    Antonov J; Popovici V; Delorenzi M; Wirapati P; Baltzer A; Oberli A; Thürlimann B; Giobbie-Hurder A; Viale G; Altermatt HJ; Aebi S; Jaggi R
    BMC Cancer; 2010 Feb; 10():37. PubMed ID: 20144231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
    Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
    Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.
    Sánchez-Navarro I; Gámez-Pozo A; González-Barón M; Pinto-Marín A; Hardisson D; López R; Madero R; Cejas P; Mendiola M; Espinosa E; Vara JA
    Biotechniques; 2010 May; 48(5):389-97. PubMed ID: 20569212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression analysis using long-term preserved formalin-fixed and paraffin-embedded tissue of non-small cell lung cancer.
    Jacobson TA; Lundahl J; Mellstedt H; Moshfegh A
    Int J Oncol; 2011 Apr; 38(4):1075-81. PubMed ID: 21305253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer.
    Mattesen TB; Rasmussen MH; Sandoval J; Ongen H; Árnadóttir SS; Gladov J; Martinez-Cardus A; Castro de Moura M; Madsen AH; Laurberg S; Dermitzakis ET; Esteller M; Andersen CL; Bramsen JB
    Nat Commun; 2020 Apr; 11(1):2025. PubMed ID: 32332866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients.
    Naoi Y; Kishi K; Tanei T; Tsunashima R; Tominaga N; Baba Y; Kim SJ; Taguchi T; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 128(3):633-41. PubMed ID: 20803240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays.
    de Ruijter TC; de Hoon JP; Slaats J; de Vries B; Janssen MJ; van Wezel T; Aarts MJ; van Engeland M; Tjan-Heijnen VC; Van Neste L; Veeck J
    Lab Invest; 2015 Jul; 95(7):833-42. PubMed ID: 25867767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study.
    Drury S; Salter J; Baehner FL; Shak S; Dowsett M
    J Clin Pathol; 2010 Jun; 63(6):513-7. PubMed ID: 20498025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA).
    Bader S; Zajac M; Friess T; Ruge E; Rieder N; Gierke B; Heubach Y; Thomas M; Pawlak M
    Mol Cell Proteomics; 2015 Oct; 14(10):2775-85. PubMed ID: 26106084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High fidelity copy number analysis of formalin-fixed and paraffin-embedded tissues using Affymetrix Cytoscan HD chip.
    Yu YP; Michalopoulos A; Ding Y; Tseng G; Luo JH
    PLoS One; 2014; 9(4):e92820. PubMed ID: 24699316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer.
    Buechler SA; Gökmen-Polar Y; Badve SS
    Clin Breast Cancer; 2019 Feb; 19(1):17-26.e8. PubMed ID: 30097312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays.
    Budczies J; Weichert W; Noske A; Müller BM; Weller C; Wittenberger T; Hofmann HP; Dietel M; Denkert C; Gekeler V
    J Histochem Cytochem; 2011 Feb; 59(2):146-57. PubMed ID: 21339180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.
    Roberts RA; Sabalos CM; LeBlanc ML; Martel RR; Frutiger YM; Unger JM; Botros IW; Rounseville MP; Seligmann BE; Miller TP; Grogan TM; Rimsza LM
    Lab Invest; 2007 Oct; 87(10):979-97. PubMed ID: 17700562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
    Kusama H; Shimoda M; Miyake T; Tanei T; Kagara N; Naoi Y; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2019 Jul; 176(1):75-85. PubMed ID: 30949799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.
    Huang YT; Li FF; Ke C; Li Z; Li ZT; Zou XF; Zheng XX; Chen YP; Zhang H
    J Transl Med; 2013 Oct; 11():245. PubMed ID: 24090193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples.
    Kalmár A; Wichmann B; Galamb O; Spisák S; Tóth K; Leiszter K; Nielsen BS; Barták BK; Tulassay Z; Molnár B
    Diagn Pathol; 2015 Jul; 10():126. PubMed ID: 26208990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation Levels of LINE-1 As a Useful Marker for Venous Invasion in Both FFPE and Frozen Tumor Tissues of Gastric Cancer.
    Min J; Choi B; Han TS; Lee HJ; Kong SH; Suh YS; Kim TH; Choe HN; Kim WH; Hur K; Yang HK
    Mol Cells; 2017 May; 40(5):346-354. PubMed ID: 28535662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.